Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1853 (LINC01853)
- Target
- LINC01853
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other
01
Overview
Long intergenic non-protein coding RNA 1853 (LINC01853) is a human lincRNA gene, transcribed as a non-coding RNA longer than 200 nucleotides that does not overlap with protein-coding genes. Unlike messenger RNAs, lincRNAs like LINC01853 function at the RNA level and do not encode proteins. They are involved in regulation of gene expression, chromatin remodeling, RNA stability, and may act as enhancers or repressors for nearby genes. While lincRNAs as a class are increasingly recognized for tissue-specific functions and involvement in developmental and disease processes (including cancer), specific biological roles and disease associations for LINC01853 itself have not been established in the literature so far. LINC01853 is mainly cited as a GeneCards entry with no direct evidence supporting its use as a therapeutic target, biomarker, or drug interaction partner.
- Other names
- LINC01853
02
Mechanism of action
Not applicable (no drugs approved or described as targeting LINC01853)
03
Biological functions
Regulation of gene expressionChromatin remodelingRNA stabilizationTranscriptional regulation, including enhancer-associated activityFine-tuning neighboring gene expression with tissue specificity
04
Disease associations
Currently, there is no direct evidence in the provided sources for a role of LINC01853 in specific diseases. However, lincRNAs in general have been implicated in diverse processes, including cancer, cell development, and disease states, but specific disease roles for LINC01853 have not been defined.
05
Safety considerations
None known
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1853 (LINC01853).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1853 (LINC01853).